BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
6/13/2016 9:14:00 AM | Browse: 287 | Download: 532
Publication Name World Journal of Gastroenterology
Manuscript ID 21610
Country of Manuscript Source Germany
2015-08-18 11:21
Peer-Review Started
2015-08-18 12:55
To Make the First Decision
2015-11-05 11:03
Return for Revision
2015-11-06 15:51
Second Decision
2016-01-12 16:28
Accepted by Journal Editor-in-Chief
2016-01-12 17:20
Accepted by Company Editor-in-Chief
2016-01-30 17:31
Articles in Press
2016-01-30 17:31
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2016-06-02 08:44
Publish the Manuscript Online
2016-06-13 09:14
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7901 Stoneridge Drive, Suite 501, Pleasanton, CA 94588, USA
Website http://www.wjgnet.com
Specialty Gastroenterology and Hepatology
Manuscript Type Retrospective Study
Article Title Last line therapy with sorafenib in colorectal cancer: A retrospective analysis
Manuscript Source Unsolicited Manuscript
All Author List Ksenia Martchenko, Irene Schmidtmann, Thomas Thomaidis, Verena Thole, Peter R Galle, Marc Becker, Markus Möhler, Thomas C Wehler and Carl C Schimanski
Funding Agency and Grant Number
Correspondence To Carl C Schimanski, Professor, Depart­ment of Internal Medicine, Marienhospital, Martinspfad 72, 64285 Darmstadt, Germany. c.schimanski@marienhospital-darmstadt.de
Keywords Colorectal cancer; Sorafenib; Regorafenib; Chemotherapy; Last line
Core Tip In this restrospective analysis we demonstrate that sorafenib monotherapy or in combination with 5-fluorouracil derivates seems to be feasible. Eighty percent of the patients showed stable disease with a median time to progression of 140.5 d and acceptable toxicity profile. In our eyes, the reported overall as well as progression free survival under sorafenib treatment are of clinical and financial interest.
Publish Date 2016-06-13 09:14
Citation Martchenko K, Schmidtmann I, Thomaidis T, Thole V, Galle PR, Becker M, Möhler M, Wehler TC, Schimanski CC. Last line therapy with sorafenib in colorectal cancer: A retrospective analysis. World J Gastroenterol 2016; 22(23): 5400-5405
Url http://www.wjgnet.com/1007-9327/full/v22/i23/5400.htm
DOI http://dx.doi.org/10.3748/wjg.v22.i23.5400
Full Article (PDF) WJG-22-5400.pdf
Full Article (Word) WJG-22-5400.doc
Revised Manuscript 21610-Review.doc
Peer-review Report 21610-Peer-review(s).pdf
Journal Editor-in-Chief Review Report 21610-Journal editor-in-chief review report.pdf
Answering Reviewers 21610-Answering reviewers.pdf
Scientific Misconduct Check 21610-Scientific misconduct check.pdf
Scientific Editor Work List 21610-Scientific editor work list.pdf
Audio Core Tip 21610-Audio core tip.mp3
Biostatistics Review Certificate 21610-Biostatistics statement.pdf
Conflict-of-Interest Disclosure Form 21610-Conflict-of-interest statement.pdf
Copyright License Agreement 21610-Copyright assignment.pdf
Data Sharing Statement 21610-Data sharing statement.pdf